 | | Frequency doubling technology for early detection and long-term management
The Humphrey Matrix represents the latest breakthrough in visual field testing. Using Frequency Doubling Technology, the Humphrey Matrix will help you conduct a thorough visual field evaluation and assess treatment alternatives. Special features include comprehensive 10-2, 24-2 and 30-2 threshold test strategies, and three options for controlling fixation. Enhanced patient management software enables you to provide complete long-term glaucoma care for your patients, so you can manage them for life.
Features Welch Allyn Frequency Doubling Technology
Frequency doubling technology provides rapid screening and full threshold test results to quickly and accurately detect the early stages of visual field loss.
World-class clinical validation
Its performance is supported by comprehensive clinical trials spanning over 3 years and an extensive age-related normative database.
Easy on your patients
- Rapid screening and full threshold results.
- Frequency doubling stimuli reduce patient anxiety during testing.
- No eye patch is necessary.
Easy on your practice
- No trial lenses required.*
- Minimal training needed – suitable for any staff member.
- Test in ambient light – no separate room required.
Expanded glaucoma management tools
Sixty-nine stimuli enable full characterization of visual field defects and an enhanced software interface and full-page printouts allow you to store, retrieve, and compare patient results over time.
Designed for long-term glaucoma patient care
The patient management software along with the 20GB hard drive make it easy to record and organize patient results for years to come. CD-R/W and floppy drives are also included for easy database archiving. A full-page color inkjet printer provides a hard copy of the comprehensive results you are accustomed to analyzing.
* Within ± 3 diopters | |  Press Article
Technical Specifications
 E-Mail
 Print this page |